Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
9.91%
Price
11:05
€316.05
Summary
This prediction is currently active. With a performance of 9.91%, the BUY prediction by Scotiabank for Amgen Inc. is trending in the right direction. Dividends of €4.90 are taken into consideration when calculating the performance. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.477% | -1.477% |
| iShares Core DAX® | -5,87 % | -2,50 % |
| iShares Nasdaq 100 | 1,66 % | 3,51 % |
| iShares Nikkei 225® | -6,13 % | 2,14 % |
| iShares S&P 500 | 0,50 % | 2,05 % |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat